{"id":43204,"date":"2020-02-25T00:31:28","date_gmt":"2020-02-24T22:31:28","guid":{"rendered":"https:\/\/newserver.fyb.de\/dermapharm-acquires-merck-subsidiary-allergopharma\/"},"modified":"2020-02-25T00:31:28","modified_gmt":"2020-02-24T22:31:28","slug":"dermapharm-acquires-merck-subsidiary-allergopharma","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/","title":{"rendered":"Dermapharm acquires Merck subsidiary Allergopharma"},"content":{"rendered":"<p>Munich \/ Rein\u00adbek \u2014 <strong>P+P P\u00f6llath + Part\u00adners<\/strong> has advi\u00adsed <strong>Derm\u00ada\u00adph\u00adarm<\/strong> Holding SE on the acqui\u00adsi\u00adtion of <strong>Aller\u00adg\u00ado\u00adpharma<\/strong> GmbH &amp; Co KG, a subsi\u00addiary of Merck KGaA, based in Rein\u00adbek near Hamburg. Through Derm\u00ada\u00adph\u00adarm Betei\u00adli\u00adgungs GmbH, the company acqui\u00adres 100% of the shares in the Merck subsidiary.<\/p>\n<p>The tran\u00adsac\u00adtion is still subject to appr\u00adoval by the rele\u00advant regu\u00adla\u00adtory autho\u00adrity; closing is expec\u00adted by the end of the second quar\u00adter of&nbsp;2020.<\/p>\n<p>Derm\u00ada\u00adph\u00adarm Holding SE, head\u00adquar\u00adte\u00adred in Gr\u00fcn\u00adwald, Germany, focu\u00adses on the produc\u00adtion and distri\u00adbu\u00adtion of high-quality derma\u00adto\u00adlo\u00adgi\u00adcal and aller\u00adgo\u00adlo\u00adgi\u00adcal phar\u00admaceu\u00adti\u00adcals. Aller\u00adg\u00ado\u00adpharma is a company specia\u00adli\u00adzed in desen\u00adsi\u00adtiza\u00adtion for allergies.<\/p>\n<p>P+P P\u00f6llath + Part\u00adners provi\u00added compre\u00adhen\u00adsive legal advice to Derm\u00ada\u00adph\u00adarm Holding SE in connec\u00adtion with the acqui\u00adsi\u00adtion with the follo\u00adwing multi\u00addi\u00adsci\u00adpli\u00adnary and multi\u00adsite&nbsp;team:<\/p>\n<p><strong>Dr. Matthias Bruse, LL.M., Photo<\/strong> (Part\u00adner, Lead Part\u00adner, Corporate\/M&amp;A, Munich)<br>\nDaniel Wied\u00admann, LL.M. (Asso\u00adcia\u00adted Part\u00adner, Anti\u00adtrust Law, Frankfurt)<br>\nDr. Matthias Werner (Coun\u00adsel, Real Estate, Berlin)<br>\nChris\u00adtine Funk, LL.M. (Senior Asso\u00adciate, IP\/M&amp;A, Frankfurt)<br>\nJasmin Wagner (Senior Asso\u00adciate, Corporate\/M&amp;A, Munich)<br>\nDr. Jesko von Mirbach, LL.M., EMBA (Asso\u00adciate, Corporate\/M&amp;A, Berlin)<br>\nDr. Lena Hummel (Asso\u00adciate, Corporate\/M&amp;A, Munich)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Munich \/ Rein\u00adbek \u2014 P+P P\u00f6llath + Part\u00adners has advi\u00adsed Derm\u00ada\u00adph\u00adarm Holding SE on the acqui\u00adsi\u00adtion of Aller\u00adg\u00ado\u00adpharma GmbH &amp; Co KG, a subsi\u00addiary of Merck KGaA, based in Rein\u00adbek near Hamburg. Through Derm\u00ada\u00adph\u00adarm Betei\u00adli\u00adgungs GmbH, the company acqui\u00adres 100% of the shares in the Merck subsi\u00addiary. The tran\u00adsac\u00adtion is still subject to appr\u00adoval&nbsp;by&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":43210,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1371],"tags":[],"class_list":["post-43204","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-deals-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dermapharm acquires Merck subsidiary Allergopharma - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dermapharm acquires Merck subsidiary Allergopharma - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Munich \/ Rein\u00adbek \u2014 P+P P\u00f6llath + Part\u00adners has advi\u00adsed Derm\u00ada\u00adph\u00adarm Holding SE on the acqui\u00adsi\u00adtion of Aller\u00adg\u00ado\u00adpharma GmbH &amp; Co KG, a subsi\u00addiary of Merck KGaA, based in Rein\u00adbek near Hamburg. Through Derm\u00ada\u00adph\u00adarm Betei\u00adli\u00adgungs GmbH, the company acqui\u00adres 100% of the shares in the Merck subsidiary. The tran\u00adsac\u00adtion is still subject to appr\u00adoval by [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-24T22:31:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"321\" \/>\n\t<meta property=\"og:image:height\" content=\"236\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Dermapharm acquires Merck subsidiary Allergopharma\",\"datePublished\":\"2020-02-24T22:31:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/\"},\"wordCount\":200,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"DEALS\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/\",\"url\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/\",\"name\":\"Dermapharm acquires Merck subsidiary Allergopharma - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg\",\"datePublished\":\"2020-02-24T22:31:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg\",\"width\":321,\"height\":236},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dermapharm acquires Merck subsidiary Allergopharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dermapharm acquires Merck subsidiary Allergopharma - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/","og_locale":"en_US","og_type":"article","og_title":"Dermapharm acquires Merck subsidiary Allergopharma - FYB Financial Yearbook","og_description":"Munich \/ Rein\u00adbek \u2014 P+P P\u00f6llath + Part\u00adners has advi\u00adsed Derm\u00ada\u00adph\u00adarm Holding SE on the acqui\u00adsi\u00adtion of Aller\u00adg\u00ado\u00adpharma GmbH &amp; Co KG, a subsi\u00addiary of Merck KGaA, based in Rein\u00adbek near Hamburg. Through Derm\u00ada\u00adph\u00adarm Betei\u00adli\u00adgungs GmbH, the company acqui\u00adres 100% of the shares in the Merck subsidiary. The tran\u00adsac\u00adtion is still subject to appr\u00adoval by [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2020-02-24T22:31:28+00:00","og_image":[{"width":321,"height":236,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Dermapharm acquires Merck subsidiary Allergopharma","datePublished":"2020-02-24T22:31:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/"},"wordCount":200,"commentCount":0,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg","articleSection":["General","Featured","News","DEALS"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/","url":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/","name":"Dermapharm acquires Merck subsidiary Allergopharma - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg","datePublished":"2020-02-24T22:31:28+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/02\/a-bruse-e1582581099336.jpg","width":321,"height":236},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/dermapharm-acquires-merck-subsidiary-allergopharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Dermapharm acquires Merck subsidiary Allergopharma"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=43204"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43204\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/43210"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=43204"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=43204"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=43204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}